Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 130 of 200 Β· By data quality, then INN

  1. matrix-applied characterised autologous cultured chondrocytes

    MACI

    EMA: unknown

    M09AX02
  2. measles, mumps and rubella vaccine (live)

    M-M-RVAXPRO

    EMA: approved

    J07BD52
  3. measles, mumps, rubella and varicella vaccine (live)

    PROQUAD

    EMA: approved

    J07BD54
  4. mecasermin rinfabate

    IPLEX

    EMA: application withdrawn

  5. melatonin

    SLENYTO Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    N05CH01
  6. melphalan flufenamide

    PEPAXTI

    EMA: approved

    L01AA10
  7. memantine

    APO-MEMANTINE Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    N06DX01
  8. meningococcal group a, c, w-135 and y conjugate vaccine

    MENQUADFI

    EMA: approved

    J07AH08
  9. meningococcal group b vaccine (rdna, component, adsorbed)

    BEXSERO

    EMA: approved

    J07AH09
  10. meningococcal group b vaccine (recombinant, adsorbed)

    TRUMENBA

    EMA: approved

    J07AH09
  11. meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed)

    PENBRAYA

    EMA: withdrawn

    J07AH11
  12. meningococcal groups a, c, w-135 and y conjugate vaccine

    NIMENRIX

    EMA: approved

    J07AH08
  13. mercaptamine

    PROCYSBI

    EMA: approved

    A16AA04
  14. mercaptamine bitartrate

    CYSTAGON

    EMA: approved

    A16AA04
  15. methylthioninium chloride

    METHYLTHIONINIUM CHLORIDE PROVEBLUE

    EMA: approved

    V03AB17
  16. mexiletine hcl

    NAMUSCLA

    EMA: approved

    C01BB02
  17. micafungin

    MYCAMINE

    EMA: approved Β· NMPA: clinical trials

    J02AX05
  18. migalastat

    GALAFOLD AMICUS THERAPEUTICS PTY LTD

    EMA: approved Β· TGA: approved

    A16AX
  19. milnacipran

    IMPULSOR

    EMA: refused

  20. mirikizumab

    OMVOH

    EMA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AC
  21. mirvetuximab soravtansine

    ELAHERE

    EMA: approved

    L01FX26
  22. mogamulizumab

    POTELIGEO KYOWA KIRIN AUSTRALIA PTY LTD

    EMA: approved Β· TGA: approved Β· PMDA: approved

    L01XC25
  23. molnupiravir

    LAGEVRIO Merck KGaA, Darmstadt, Germany

    EMA: application withdrawn Β· TGA: approved Β· PMDA: approved

    J05A
  24. momelotinib

    OMJJARA GlaxoSmithKline

    EMA: approved Β· TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.